Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 12, 2026Cancer Nursing Practice

Controlled cooling therapy for the prevention of chemotherapy-induced peripheral neuropathy: a service evaluation

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLaura Collantes-EspinosaETElaine TomlinsWGWendy Gill

Discussion

Loading...

Member takes

Overview

Service evaluation reports on cooling therapy reducing chemotherapy-induced peripheral neuropathy in cancer patients, suggesting clinical potential.

Key Points

  • This evaluation assesses the feasibility and impact of controlled cooling therapy on preventing chemotherapy-induced peripheral neuropathy (CIPN) in cancer patients.
  • Nurse-led service evaluation of a cooling device during chemotherapy in a medical day unit.
  • Twelve patients with various types of cancer received cooling therapy while undergoing chemotherapy.
  • Adherence and outcomes were monitored and evaluated post-treatment.
  • Eight patients adhered fully to the cooling device, leading to four developing grade 1 CIPN and four remaining neuropathy free.
  • Three months post-treatment, seven patients reported no CIPN and one experienced grade 1 CIPN.
  • Most patients found the cooling device tolerable, though some had adherence challenges due to prolonged mitten use.

Cite This Study

Collantes-Espinosa et al. (2026) studied this question.

synapsesocial.com/papers/6a2ba3d18101cf8926f02708https://doi.org/10.7748/cnp.2026.e1912
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Chemotherapy-induced peripheral neuropathy: where are we now?2019 · 344 citations
  2. 2A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system2023 · 13 citations
  3. 3Chemotherapy-induced peripheral neuropathy in patients treated with taxanes and platinum derivatives2015 · 222 citations
  4. 4Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update2020 · 1,136 citations